Benigno Varela Fernandez
Hematology & Oncology · San Juan, PRNPI 1255319380
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,309 of the $8,189 with a category attached, or 64.8%. 24 manufacturers reported payments, led by Johnson & Johnson at 40.1% of the total. Reporting peaked in 2019 at $3,629 and has fallen 65.5% since, to $1,250 in 2022. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 253 payments — averaging $32.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- AstraZeneca$584
- Eli Lilly Export S.A. Puerto Rico Branch$487
- Genentech USA, Inc.$476
- PBG Puerto Rico LLC$474
- AbbVie$407
- plus $2K from 18 others
What the payments were for
- Consulting fees$2,38029%
- Travel & lodging$120%
- Food & beverage$5,30965%
- Education$4886%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 32 | $3,281 |
| AstraZeneca | 29 | $584 |
| Eli Lilly Export S.A. Puerto Rico Branch | 17 | $487 |
| Genentech USA, Inc. | 23 | $476 |
| PBG Puerto Rico LLC | 22 | $474 |
| AbbVie | 19 | $407 |
| Amgen | 20 | $406 |
| Sanofi | 15 | $341 |
| GSK | 14 | $312 |
| Merck | 15 | $279 |
| Novartis | 10 | $231 |
| Bayer | 8 | $187 |
| Bristol Myers Squibb | 5 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $132 |
| E.r. Squibb & Sons, L.L.C. | 6 | $119 |
| Taiho Oncology, Inc. | 5 | $96 |
| Sanofi-aventis U.S. LLC | 2 | $45 |
| Shire North American Group Inc | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Exelixis Inc. | 1 | $27 |
| Seagen Inc. | 1 | $20 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $18 |
| Pfizer Pharmaceuticals LLC | 1 | $17 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMBRUVICA$2,380
How this compares
$8,189 in reported general payments places this provider in the 40th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in San Juan
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Edgardo Santiago-GuzmanSan Juan$79K
- Adelba Torres-LopezSan Juan$73K
- Karla Feliciano SalvaSan Juan$44K
- Luis Delgado MateuSan Juan$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.